The occurrence of cystic fibrosis is very rare in the Asian population. Carriers of the mutations most commonly found in Caucasians were not detected in a large Asian population sample of almost 900 chromosomes. However, an affected Pakistani child born to consanguineous parents was further investigated and shown to be homozygous for the mutation S549N (G-8A). Molecular and clinical data are presented which may improve our understanding of the phenotypic effects of the S549N mutation in the
Cystic fibrosis (CF) is reported to be one of the most common severe recessive disorders in the Caucasian population.' The carrier frequency among Caucasians averages about 1/25.
A mutation has been identified in the CF gene whose frequency increases in a south-east to north-west gradient from 30% in Turkey to 87% in Denmark.2 The mutation is a deletion of CTT in exon 10 which results in the removal of a phenylalanine residue at amino acid position 508 (A F508) Heterozygotes for the A F508 mutation were identified after electrophoresis of the exon 10 PCR products on 10% neutral polyacrylamide gels when heteroduplex bands were clearly visible after ethidium bromide staining.
The S549 mutation was detected by the removal of a DdeI site and G551D and R553X mutations were identified by the creation of an MboI site and the removal of a HinclI site respectively in the exon 11 PCR product. DNA SEQUENCING PCR products for sequencing were prepared in reaction mixes containing one 5' biotinylated primer and one normal primer. The double stranded product was denatured in 0-15 mol/l NaOH and the biotinylated strand was separated from the non-biotinylated strand using magnetic streptavidin coated beads (Dynabeads, Dynal UK Ltd). The biotinylated strand was sequenced from the original nonbiotinylated PCR primer by the dideoxy chain formation method using a USB sequenase version 2 0 DNA sequencing kit and 35S dATP as the radioactive label.
Results
Thirteen CF heterozygotes (5 8%) were detected among the 222 unrelated Caucasians from the north-east of England. Eleven of these carried the A F508 mutations and two had the G551D mutation. None of the unaffected Asian samples tested (400 unrelated Indians, 43 unrelated orientals) were AF508, G551D, R553X, or S549 carriers.
The five members of the Pakistani family tested negative for the AF508, G551D and R553X mutations, but the affected child appeared homozygous for the rare exon 11 S549 mutation when the PCR product failed to digest with DdeI. This was confirmed when both parents were shown to be S549 heterozygotes as presented in fig 1. The exon 11 PCR products from both of her unaffected brothers, however, digested completely with DdeI. Sequencing results of PCR products from the mother, the affected child, and one unaffected child are shown in fig 2. These show a G to A substitution at cDNA nucleotide position 1778 which creates the S549N (Ser-+Asn) mutation in the CFTR protein previously described by Cutting et al.4
Discussion Cystic fibrosis has rarely been described in subjects from the Asian population. No carriers of the commonest Caucasian CF mutation (AF508) or of the less common G551D, R553X, and S549N mutations were detected in an Asian population of 443 unrelated subjects, even though the frequency of 5-8% in our population was slightly greater than expected. However, the presence of other CF mutations cannot be excluded when the emerging molecular heterogeneity of CF is considered.
Schwartz et all2 reported six affected Pakistani children, all with consanguineous parents, of whom three were homozygous for A F508 and three had unidentified mutations. The affected Pakistani child studied here is homozygous for a rare CF mutation, S549N. Homozygosity is not unexpected considering the close relationship of her parents. The detection of this mutation allowed carrier testing for her two unaffected brothers, neither of whom were shown to carry the S549N mutation (figs 1 and 2).
Some 80 to 85% of CF patients have the severe pancreatic insufficient form of the disease. If these patients are homozygous for 'severe' alleles which are recessive to the putative 'milder' alleles associated with pancreatic sufficiency, then the frequency of severe alleles must be 90 to 92%. However, compound ± 1 2 3 4 5 6 7 8 9 10 95 bp -_ 58 bp -* 37 bp - Figure 1 Lanes 1, 3, 5, 7, and 9 show the 95 bp undigested CFTR exon 11 PCR product. Lanes 2, 4, 6, 8, and 10 show the PCR product after DdeI digestion which produces fragments of 58 bp and 37 bp. The lanes correspond to the subjects shown in the pedigree directly above. Both parents are heterozygous for the presence of the DdeI restriction site, both unaffected sons are homozygous for the presence of the site, and the affected daughter is homozygous for absence of the site. 
